EKSO BIONICS (23E2) Stock Statistics & Valuation Metrics

EKSO BIONICS has a market cap or net worth of $11.24M. The enterprise value is €14.52M.

EKSO BIONICS has 29,017,693 shares outstanding. The number of shares has decreased by -2.65% in one year.

EKSO BIONICS’s return on equity (ROE) is -0.89 and return on invested capital (ROIC) is -50.31%.

The current PE Ratio of EKSO BIONICS is -1.09. EKSO BIONICS’s PEG ratio is 0.02.

In the last 12 months, EKSO BIONICS had revenue of 17.93M and earned -11.33M in profits. Earnings per share was -0.56.

In the last 12 months, operating cash flow was -9.85M and capital expenditures -37.00K, giving a free cash flow of -9.88M billion.

EKSO BIONICS pays an annual dividend of ―, resulting in a dividend yield of ―

EKSO BIONICS upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.

EKSO BIONICS as a current ratio of 2.50, with Debt / Equity ratio of 47.08%

In the past 12 months, EKSO BIONICS has paid 0.00 in taxes.

EKSO BIONICS EV to EBITDA ratio is -1.25, with an EV/FCF ratio of -1.20.

EKSO BIONICS has $6.49M in cash and marketable securities with $17.78K in debt, giving a net cash position of -$510.00K billion.

Gross margin is 53.06%, with operating margin of -58.35%, and net profit margin of -63.21%.

The average price target for EKSO BIONICS is $4.38, which is 11.43% higher than the current price. The consensus rating is Moderate Buy